This came after MSN Laboratories presented the literature on additional efficacy data on Tolvaptan tablets 7.5 mg, approved ...
StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report released on Monday morning. The firm issued a hold rating on the specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback